🇺🇸 FDA
Patent

US 9580492

Monoclonal antibodies that neutralize anthrax toxins

granted A61KA61K2039/505A61K51/1009

Quick answer

US patent 9580492 (Monoclonal antibodies that neutralize anthrax toxins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61K51/1009, A61P, A61P31/04